TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
The third batch of standards officially released the standard coverage of implants
 
Author:中国铭铉 企划部  Release Time:2017-9-27 11:28:04  Number Browse:2067
 
Medical network - September 26, medicine economic newspaper reporter learns from Chinese medicine and health products import and export chamber of commerce, white willow bark extract, betel nut polysaccharide polyphenol, seaweed extract (fucus xanthine) order of merit of three groups of plant extracts international business standards, a total of 12. So far, the health care chamber has completed the first three or 25 criteria.

Plant extract has always been a major category of Chinese medicine products. Since the first batch of international business standards for plant extracts was released by the health care chamber in 2013, the standard gap has been filled. In this standard setting, the health insurance chamber will work with the national standard publishing house for the first time, standardize the standard, and officially publish the standard single copy of plant extracts from the standard publishing house. At the same time, we will continue to maintain standard integrity this year and publish the standard set of plant extracts (2017 edition). It is reported that the first and second batch of 13 standard revision work is under way, and the revised edition will be released in the near future. Yu zhibin, director of the Chinese medicine department of the health insurance chamber, expects the results of the fourth batch of international business standards for plant extracts to be published in June next year.

Enhance international discourse power

"China's plant extraction technology, technology and equipment are close to the international advanced level, but the standardization and market management of the plant extract industry are relatively backward." In an interview with the media, the director of Chenguang Biotech Group Co., Ltd., said that there were frequent incidents of shoddy and shoddy work in the industry.

In recent years, the plant extract industry has been developing rapidly and has been widely used in food, medicine, chemical industry and other fields. It is an important export of Chinese traditional Chinese medicine products and occupies half of the mountain. However, the current standard of plant extract industry is lacking, which is not strong with international standard, and the export of plant extracts is vulnerable. In addition, the competition of plant extract international market is very fierce, in this context, accelerating the transformation and upgrading of plant extraction industry, improving the export quality of plant extracts is a top priority.

"Plant extracts increasingly highlight quality control lack of standards and specifications, become the bottleneck of restricting our plant medicine exportation, the standards and launch will be more conducive to plant extracts enterprises to exploit domestic and international markets." According to health care chamber of commerce, the domestic market, through inspection institute in cooperation with China, will form a special plant extracts standard set, in the future become an important source of health food for the record materials directory, also will be the most important source of raw material procurement for healthcare companies; The international market, in cooperation with USP, will form a mutual recognition standard set between China and the United States, which will facilitate the development of sino-us trade. At the same time, the standard will also become the important standard basis for China's foreign trade, and more conducive to Chinese enterprises mastering the negotiating power.

"Some varieties have begun to initiate bilateral mutual recognition, such as willow twig extract, xanthocyanin and green bean extract, but there is still a distance between them." Interview, Yu Zhibin told medicine economic newspaper reporters: "in fact, the United States pharmacopoeia also studies have been carried out to standards set by the chamber of commerce, they are interested in this a few varieties, plans to be included in the United States pharmacopoeia, so both sides start the mutual recognition, at the same time, we in the United States pharmacopoeia dietary supplement ingredients approved parts are also going to adopt."

In addition reporter noticed that the extracts of 2016, China's top ten export varieties include: stevia extract, eucalyptus oil, menthol, licorice extract, marigold extract, chilli pigment, cranberry extract, rutin and its derivatives, hesperidin, cassia oil, etc. But the top-ranked varieties of eucalyptus oil, menthol and liquorice extract are not currently on the list of 25 existing criteria.

"Our goal is to cover all plant extract products, but standard development requires a process that can be activated before it can be started. At present, the development of standards is slow, mainly because there are too few plant extracts in China, so the future standard will be more say. "Said the expert.

The other is worth mentioning, plant extracts of international business is a recommended standard is not mandatory standards, industry officials said in an interview, look to the actual situation of most domestic enterprises, the basic can be achieved.

Make a long plate and make up the short board

The report by the forward-looking industry research institute shows that the steady growth in demand for plant extracts from developed countries and regions, especially in Europe and the United States, has greatly stimulated the development of the industry. In 2006, global sales of plant extracts reached us $10.14 billion, reaching us $33.32 billion in 2016, with annual market growth of about 12.63%.

In the context of the growing scale of the global herbal medicine market, the global market for plant extracts has continued to rise in 2016, and has formed a situation of beauty, Germany, Japan and France. Germany's market for plant extracts has grown faster than the United States, with plant extracts accounting for 22.68 percent of global sales. The United States also has a big advantage, with a ratio of 22.21%. Once again, Japan, with a market size of 19.75 percent of the market for plant extracts, is approaching 20 percent. France accounted for 13.21 percent. China has been developing rapidly in recent years and is becoming more and more important in the world. The market share of plant extracts is 7.16%.

In 2016, China exported extracts from 150 countries and regions, according to the China import and export chamber of commerce. Asia, Europe and the americas are the leading export markets, accounting for nearly 90 percent of exports. Asia is the largest export market of extracts, in 2016 China's exports to Asia amount is 5.81 billion yuan, accounting for 45.70% of total exports, by the association of south-east Asian nations (asean) essential oil products market fell sharply, China's exports to Asia fell 13.63%. While exports to Europe and North America were mainly non-essential oil products, they were more stable and less volatile, with exports of 27.2 billion yuan and 2.88 billion yuan respectively.

"In the field of plant extract, basically domestic raw materials are close to international advanced level in technology, technology and equipment, and also have advantages in price." Despite this, Chen snow, head of market research at the Chinese market, believes that there are also shortboards in the field of plant extracts. "Such as domestic spending on research and development of enterprises is not very enough, inadequate health improve the function of the material for research in particular, it will also become the disadvantages of the development of downstream products, need to enterprise lacking."

"In the market competition, with the elimination of a batch of poorly managed and poorly managed enterprises, the concentration of the industry has increased and a number of competitive enterprises can directly participate in international competition." Cic adviser in the 2016-2020, the Chinese plant extracts market investment analysis and prospect forecast report pointed out that these advantages businesses generally have the following in common: extraction technology has taken the lead, quality, production level, and has the capability of a variety of products processing; It has established its own raw material base, which can control the quality of raw materials and realize the integration of raw materials and finished products. The international market has a fixed customer group, has a certain popularity, has the strong research and development strength.

 
Previous article:The seven treatment areas will become the pharmaceutical giants' main source of revenue!
Next article:NO !
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粤公网安备 44011202000029号